Thrombectomy Devices Market

Executive Summary

Thrombectomy Devices Market was valued at US $1.29 billion in 2021 and is projected to grow at 7.66% CAGR over the forecast period to reach US $2.01 billion by 2027. Thrombectomy Devices Market represented US $0.18 billion opportunity over 2019-2021 and estimated to create US $0.72 billion opportunity in 2027 over 2021.

Thrombectomy Devices from Consainsights analyses the Thrombectomy Devices Market in the Life Sciences industry over the forecast period to 2027.

Thrombectomy Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Thrombectomy Devices segmentation includes Type, Application, End User, Region and Geography.

Based on the Type, the Thrombectomy Devices analysis covers Aspiration Thrombectomy System, Mechanical/Fragmentation Thrombectomy System, Rheolytic/Hydrodynamic Thrombectomy System, Ultrasonic Thrombectomy System.

In Type segment, Aspiration Thrombectomy System segment has highest cagr growth of 6.78%.

Based on the Application, the Thrombectomy Devices analysis covers Cardiovascular Applications, Neurovascular Applications, Peripheral Vascular Applications.

In Application segment, Cardiovascular Applications segment has highest cagr growth of 6.78%.

Based on the End User, the Thrombectomy Devices analysis covers Hospitals And Surgical Centers, Ambulatory Surgical Centers, Research Laboratories And Academic Institutes, Other End Users.

In End User segment, Hospitals And Surgical Centers segment has highest cagr growth of 6.78%.

Based on the Region, the Thrombectomy Devices analysis covers North America, Europe, Asia-Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 6.78%.

Based on the region, the Thrombectomy Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Geographic Benchmarking, Top Market Players, Emerging Players and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Aspiration Thrombectomy System segment has the highest revenue of US $0.53 billion and is expected to grow at CAGR of 6.78% by 2027 Aspiration Thrombectomy System segment has highest cagr growth of 6.78%.

Aspiration Thrombectomy System

Aspiration Thrombectomy System segment was valued at US $0.46 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.82 billion by 2027. Aspiration Thrombectomy System segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.29 billion opportunity in 2027 over 2021.

Mechanical/Fragmentation Thrombectomy System

Mechanical/Fragmentation Thrombectomy System segment was valued at US $0.35 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.63 billion by 2027. Mechanical/Fragmentation Thrombectomy System segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.23 billion opportunity in 2027 over 2021.

Rheolytic/Hydrodynamic Thrombectomy System

Rheolytic/Hydrodynamic Thrombectomy System segment was valued at US $0.21 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.37 billion by 2027. Rheolytic/Hydrodynamic Thrombectomy System segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.13 billion opportunity in 2027 over 2021.

Ultrasonic Thrombectomy System

Ultrasonic Thrombectomy System segment was valued at US $0.10 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.18 billion by 2027. Ultrasonic Thrombectomy System segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.07 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Cardiovascular Applications segment has the highest revenue of US $0.69 billion and is expected to grow at CAGR of 6.78% by 2027 Cardiovascular Applications segment has highest cagr growth of 6.78%.

Cardiovascular Applications

Cardiovascular Applications segment was valued at US $0.59 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $1.07 billion by 2027. Cardiovascular Applications segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.38 billion opportunity in 2027 over 2021.

Neurovascular Applications

Neurovascular Applications segment was valued at US $0.39 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.70 billion by 2027. Neurovascular Applications segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.25 billion opportunity in 2027 over 2021.

Peripheral Vascular Applications

Peripheral Vascular Applications segment was valued at US $0.13 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.24 billion by 2027. Peripheral Vascular Applications segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.09 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals And Surgical Centers segment has the highest revenue of US $0.62 billion and is expected to grow at CAGR of 6.78% by 2027 Hospitals And Surgical Centers segment has highest cagr growth of 6.78%.

Hospitals And Surgical Centers

Hospitals And Surgical Centers segment was valued at US $0.53 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.96 billion by 2027. Hospitals And Surgical Centers segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.34 billion opportunity in 2027 over 2021.

Ambulatory Surgical Centers

Ambulatory Surgical Centers segment was valued at US $0.29 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.53 billion by 2027. Ambulatory Surgical Centers segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.19 billion opportunity in 2027 over 2021.

Research Laboratories And Academic Institutes

Research Laboratories And Academic Institutes segment was valued at US $0.21 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.38 billion by 2027. Research Laboratories And Academic Institutes segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.14 billion opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $0.08 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.14 billion by 2027. Other End Users segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.05 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $0.50 billion and is expected to grow at CAGR of 6.78% by 2027 North America segment has highest cagr growth of 6.78%.

North America

North America segment was valued at US $0.43 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.78 billion by 2027. North America segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.28 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $0.27 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.49 billion by 2027. Europe segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

Asia-Pacific

Asia-Pacific segment was valued at US $0.26 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.47 billion by 2027. Asia-Pacific segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $0.15 billion in 2019 and is projected to grow at 6.78% CAGR over the forecast period to reach US $0.27 billion by 2027. Rest of the World segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.10 billion opportunity in 2027 over 2021.